Annual report pursuant to Section 13 and 15(d)

INCOME TAXES (Tables)

v3.22.4
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2022
INCOME TAXES  
Schedule of components of loss before provision for income taxes

During the years ended December 31, 2022, 2021, and 2020, the Company recorded $1.5 million, $29.7 million and $0.9 million, respectively, of income tax benefit, which was primarily driven by book losses and a partial release of the valuation allowance related to the deferred tax liabilities acquired on various acquisitions during 2021. For financial reporting purposes, loss before provision for income taxes, includes the following components (in thousands):

Years Ended December 31, 

    

2022

    

2021

    

2020

Domestic

$

(474,942)

$

(252,343)

$

(34,285)

Foreign

 

(266,899)

 

(17,659)

 

(670)

Loss before income taxes

$

(741,841)

$

(270,002)

$

(34,955)

Schedule of provision (benefit) for income taxes

The provision (benefit) for income taxes consists of the following (in thousands):

Years Ended December 31, 

2022

    

2021

    

2020

Current:

Federal

$

$

(33)

$

Foreign

368

State

35

20

Total Current

403

(13)

Deferred:

Federal

196

(23,378)

(670)

State

16

(5,494)

(270)

Foreign

(2,113)

(783)

Total Deferred

(1,901)

(29,655)

(940)

Benefit for income taxes

$

(1,498)

$

(29,668)

$

(940)

Schedule of reconciliation of the expected income tax benefit computed using the federal statutory income tax rate

Years Ended December 31, 

    

2022

    

2021

    

2020

    

Effective income tax rate:

Expected income tax benefit at the federal statutory rate

 

21

%

 

21

%

 

21

%

State taxes

2

%

(2)

%

6

%

Change in valuation allowance

(9)

%

(4)

%

(68)

%

Goodwill impairment

(15)

%

%

%

Research and development credit carryover

%

(1)

%

2

%

Stock-based compensation expense

(1)

%

3

%

%

Warrant Expense

%

(5)

%

%

Permanent differences

%

%

42

%

Other

2

%

(1)

%

%

Effective income tax rate

(0)

%

11

%

3

%

Schedule of deferred tax assets and liabilities

As of the years ended December 31, 2022 and 2021, deferred tax assets and liabilities consist of the following (in thousands):

Years Ended December 31, 

    

2022

    

2021

Deferred tax assets:

Federal and state net operating carryforwards

$

185,842

$

148,946

Research and development and other credits

10,974

10,977

Start-up costs

11,854

12,904

Stock-based compensation

3,554

4,242

Capitalized research and development

20,793

Reserves and accruals

3,311

1,452

Deferred lease liability

7,581

4,856

Depreciation

3

Divisional foreign entity deferred

2,137

Other deferred tax assets

7,960

6,457

Total gross deferred tax asset

251,869

191,974

Valuation allowance

(195,309)

(127,150)

Net deferred tax asset

56,560

64,824

Deferred tax liabilities:

Right‑of‑use asset

(7,234)

(4,692)

Intangible assets

(56,794)

(68,504)

Depreciation

(962)

(1,527)

Other

(796)

Total deferred tax liabilities

(64,990)

(75,519)

Net deferred tax liability

$

(8,430)

$

(10,695)

Schedule of changes in the valuation allowance for deferred tax assets

Changes in the valuation allowance for deferred tax assets during the years ended December 31, 2022 and 2021 were as follows (in thousands):

Years Ended December 31, 

    

2022

    

2021

Valuation allowance at beginning of the year

$

127,150

$

111,494

Increases recorded to income tax provision

 

68,159

 

45,139

Decreases recorded as a benefit to income tax provision

(29,483)

Valuation allowance at end of year

$

195,309

$

127,150

Schedule of reconciliation unrecognized tax liabilities

Years Ended December 31, 

2022

    

2021

Unrecognized tax liability, beginning of year

$

997

$

Unrecognized tax liability acquired through purchase accounting

1,005

Gross decreases - foreign exchange translation adjustments

(8)

Unrecognized tax liability, end of year

$

997

$

997